Placenta, Umbilical Cord, and Umbilical Cord Blood as a Source of Therapeutic Cells

Overview

About this study

The purpose of this study is to collect, isolate and culture progenitor cells.  To determine optimal methods for isolation, culture, transfection, and differentiation of these cells with potential therapeutic uses.  To act as a central resource for the investigation of these cells for researchers at the Mayo Clinic.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

Inclusion Criteria:

  • Patients age 18 and older in their second or third trimester of normal pregnancy will be eligible to participate in this research study.  

Exclusion Criteria: 

  • Abnormal pregnancy that may include birth defects of the fetus, maternal complications with the placenta or umbilical cord anatomy, and/or any complications during the birthing process

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Allan Dietz, Ph.D.

Contact us for the latest status

Contact information:

Myra Wick M.D., Ph.D.

(507)538-5809

Wick.Myra@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20315010

Mayo Clinic Footer